Teladoc Health TDOC Ratios & Valuation
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| Profitability | |||||
| Gross margin | 69.5%-1.3pp | 70.8%0.0pp | 70.8%+1.7pp | 69.1%+1.1pp | |
| Operating margin | -10.4%+29.3pp | -39.7%-30.2pp | -9.6%+558pp | -567.3%-554pp | |
| Net margin | -7.9%+31.0pp | -39%-30.5pp | -8.5%+559pp | -567.5%-546pp | |
| Returns | |||||
| Return on equity | -13.9%+38.5pp | -52.5%-42.9pp | -9.5%+139pp | -148.8%-146pp | |
| Return on invested capital | -36.6%+63.4pp | -100%-81.6pp | -18.4%+146pp | -164%-162pp | |
| Efficiency | |||||
| Asset turnover | 0.8×+0.1× | 0.6×+0.1× | 0.6×+0.4× | 0.2×+0.1× | |
| Liquidity | |||||
| Current ratio | 2.8×+1.0× | 1.8×-1.8× | 3.5×+0.2× | 3.3×-0.4× | |
| Leverage | |||||
| Debt-to-equity | 0×-0.4× | 0.4×+0.4× | 0×0.0× | 0×0.0× | |
| Net debt / EBITDA | -8.4×— | —— | -12.5×— | —— | |
| Per Share | |||||
| Book value per share | $7.86-10.1% | $8.74-38.1% | $14.13-1.1% | $14.29-86.0% | |
| Valuation | |||||
| Market capitalization | $1.41B+16.5% | $1.56B-56.3% | $3.58B-6.6% | $3.83B-73.9% | |
| Price / sales | 0.6×+0.1× | 0.6×-0.8× | 1.4×-0.2× | 1.6×-5.6× | |
| Price / book | 1.1×+0.2× | 1×-0.5× | 1.5×-0.1× | 1.7×+0.7× | |
| EV / EBITDA | 4.6×— | —— | 29.3×— | —— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Teladoc Health's profit margins?
- Teladoc Health (TDOC) runs a 69.3% gross margin and a -8.1% operating margin, with a -6.8% net margin.
- Where do Teladoc Health's ratios come from?
- Every ratio is computed from Teladoc Health's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
